Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/13/1988 | EP0252760A2 Process to prepare solid products containing oil-soluble substance |
01/13/1988 | EP0252759A2 Process to prepare solid products containing oil-soluble substance |
01/12/1988 | US4719312 Lysosometropic detergent therapeutic agents |
01/12/1988 | US4719239 Pharmaceutical multicomponent systems and method of preparing same |
01/12/1988 | US4719228 Free-flowing power |
01/07/1988 | EP0252044A1 Test strip and method for epicutaneous testing |
01/07/1988 | EP0252033A2 A "gel" pharmaceutical form containing N-(2.6-Dichloro-M-Tolil)-Anthranilic acid (mechlophenamic acid) for use in therapy by topical application |
01/07/1988 | EP0252004A1 Pharmaceutical compositions for parenteral application |
01/07/1988 | EP0251905A2 Esters of alginic acid |
01/07/1988 | EP0251680A2 Controlled release bioerodible drug delivery system |
01/07/1988 | EP0251657A2 Therapeutic compositions with galactitol as carrier |
01/07/1988 | EP0251494A2 Therapeutic or radiodiagnostic compound |
01/07/1988 | EP0251476A1 Controlled release of macromolecular polypeptides |
01/07/1988 | EP0251459A2 Controlled release pharmaceutical composition |
01/07/1988 | EP0251455A2 Amine derivatives of folic acid analogs |
01/07/1988 | EP0251369A2 Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them |
01/07/1988 | EP0251330A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them |
01/07/1988 | EP0251229A1 Polymerizable beta-glycerophospholipid and method for production thereof |
01/07/1988 | EP0251001A2 Stabilization of an interleukin-2 preparation for therapeutical use |
01/07/1988 | EP0250802A1 Liquid ibuprofen preparations |
01/07/1988 | EP0250542A1 Transdermal delivery system. |
01/07/1988 | EP0250492A1 Biodegradable synthetic polypeptide and its utilization in therapeutics |
01/07/1988 | EP0250486A1 Melphalan derivatives |
01/07/1988 | EP0250477A1 Enzyme-coupled antibodies |
01/07/1988 | EP0140728B1 Cytotoxic pharmaceutical association, especially suited for the treatment of cancers |
01/06/1988 | CN86108858A Prescription of the membrane-typed white arsenic dental pulp devitalized drug |
01/05/1988 | US4717717 Water soluble cellulose polymer as stabilizer |
01/05/1988 | US4717713 Controlled release liquid pharmaceutical |
01/05/1988 | US4717565 Process for the preparation of medicament adsorbates |
01/05/1988 | CA1231192A1 Binder for low density lipoproteins |
01/05/1988 | CA1231052A1 Vehicle suitable for use in medicinal preparations |
12/30/1987 | WO1987007902A1 Coatings based on polydextrose for aqueous film coating of pharmaceutical, food and confectionery products |
12/29/1987 | US4716203 Diblock and triblock copolymers |
12/29/1987 | US4716173 Lengthening time of circulation of drug in plasma |
12/29/1987 | US4716153 Stable oral preparation of macrolide antibiotics and method for stabilizing the same |
12/29/1987 | US4716033 Good-tasting |
12/29/1987 | CA1230888A1 Polyanionic compositions derived from aromatic ethers of polyglycerol |
12/23/1987 | EP0250038A2 Sustained release capsule |
12/23/1987 | EP0250023A1 Nitrofurantoin dosage form |
12/23/1987 | EP0249949A2 Sustained release pharmaceutical preparations |
12/23/1987 | EP0249811A1 New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient |
12/23/1987 | EP0249736A2 Ointment for the treatment of skin diseases |
12/23/1987 | DE3719818A1 Pharmaceutical compositions |
12/22/1987 | US4714759 Immunotoxin therapy of allergy |
12/22/1987 | US4714758 Mono- or dicarboxylic acids; for cosmetics, foods or medicines |
12/22/1987 | US4714713 Phenylalanine derivatives and uses thereof |
12/22/1987 | US4714611 Stable composition of gamma-interferon |
12/22/1987 | CA1230700A1 Alkyl acrylamide-containing emulsion copolymers for thickening purposes |
12/22/1987 | CA1230555A1 Products and methods for treatment of cancer |
12/22/1987 | CA1230554A1 Edible composition containing vaccines |
12/17/1987 | WO1987007618A1 Acid decrystallization of aminopolysaccharides and derivatives thereof |
12/17/1987 | WO1987007504A1 Pharmaceutical composition for the nasal administration of heparin and method for treatment of patients |
12/16/1987 | EP0249587A1 Solid pharmaceutical preparation with extended release and process for its preparation |
12/16/1987 | EP0249397A2 Improved penetrating topical pharmaceutical compositions |
12/16/1987 | EP0249194A2 Topical prostaglandin formulations |
12/16/1987 | EP0249193A2 Vehicle for topical application of pharmaceuticals |
12/16/1987 | EP0249008A2 Use of specific monosaccharides for the preparation of a medicament for the prevention of metastases of malignic tumours |
12/16/1987 | EP0248885A1 Transdermal delivery of drugs. |
12/15/1987 | US4713398 Naturally-derived carotene/oil composition |
12/15/1987 | US4713249 Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof |
12/15/1987 | US4713246 Etoposide oral dosage form |
12/15/1987 | US4713244 Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
12/15/1987 | US4713237 Sustained release dosage form |
12/10/1987 | DE3619083A1 Therapeutic composition for preventing acute heart death of livestock for slaughter due to stress |
12/09/1987 | EP0248740A2 A composition of aluminium hydroxide gel |
12/09/1987 | EP0248548A2 Controlled release pharmaceutical composition |
12/09/1987 | EP0248051A1 Pharmaceutical composition including sodium cromoglycate |
12/09/1987 | EP0078820B1 Inclusion complexes of n-(1-phenylethyl)-3,3-diphenylpropylamine respectively the hydrochloride thereof with cyclodextrin, a process for the preparation of these inclusion complexes as well as pharmaceutical preparations containing these inclusion complexes |
12/09/1987 | CN87104249A Superoxide dismutase derivatives, method of producing same and medicinal use of same |
12/09/1987 | CN87103409A Prepn. of solid pharmaceutical forms |
12/08/1987 | US4711906 Mixture of propylene glycol and polyoxyethylene glycol and water |
12/08/1987 | US4711902 Fatty acid ester |
12/08/1987 | US4711894 Potency stabilizers of ascorbic acid, citric acid, cysteine and-or methionine |
12/08/1987 | US4711784 High molecular weight polyvinyl acetate blended with hydrophobic plasticizer |
12/08/1987 | US4711777 Ion exchange resins |
12/08/1987 | US4711774 Medicament adsorbates with complex magnesium aluminum silicate and their preparation |
12/08/1987 | CA1230186A1 Cross-linked gels of hyaluronic acid and products containing such gels |
12/07/1987 | EP0191771A4 Automatic injector assembly. |
12/03/1987 | WO1987007263A1 Composition containing linolenic acid compound |
12/03/1987 | WO1987007150A1 Receptor-targeted drug delivery systems |
12/03/1987 | WO1987007149A1 Pharmaceutical compositions |
12/03/1987 | WO1987007145A1 D-gl conjugate therapy |
12/03/1987 | WO1987007140A1 Sustained-release pharmaceutical compositions |
12/03/1987 | WO1987007139A1 Body powder in liquid form, body powder containing active ingredients and method of preparing thereof |
12/03/1987 | DE3716437A1 Pharmazeutische zusammensetzung Pharmaceutical composition |
12/02/1987 | EP0247983A2 New pharmaceutical preparation for oral use |
12/02/1987 | EP0247900A1 Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease |
12/02/1987 | EP0247899A2 Substance useful as a thickening agent and/or emulsion stabilizer |
12/02/1987 | EP0247860A2 Tumor necrosis factor formulation and its preparation |
12/02/1987 | EP0247792A2 Immunoglobulin conjugates |
12/02/1987 | EP0247634A2 Coated dosage forms |
12/02/1987 | EP0247616A2 Stabilization of multivitamin/trace elements formulations |
12/02/1987 | EP0247584A2 Use of ethylene oxide-propylene oxide block polymers in the control of foam in liquid pharmaceutical preparations. |
12/02/1987 | EP0247552A2 Self-emulsifying fat for pharmaceutical and cosmetic use, preparation and use thereof |
12/02/1987 | EP0247507A2 Composition for transdermal therapeutical systems of high-ceiling diuretics, and process for producing it |
12/02/1987 | EP0247362A2 Hydroxyalkyl cellulose-containing gel preparation |
12/02/1987 | EP0247114A1 Lipid containing plastics. |
12/01/1987 | US4710517 Maltose, lactose stabilizers; anticarcinogenic agents, immunomodulators |
12/01/1987 | US4710497 Fatty acid ester and benzodiazepines carrier |
12/01/1987 | US4710376 Topical therapeutic composition containing oxidation inhibitor system |